CAS RN: 1373422-53-7

GSK J1

Product Availability

Choose a grade to view its available package options.

14 package records13 with current stock3 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250128 100mg In stock Shanghai Inquiry
Batchno.20251107 10mg In stock Shanghai Inquiry
Batchno.20250126 1g In stock Shanghai Inquiry
Batchno.20250530 1mg In stock Shanghai Inquiry
Batchno.20250415 250mg In stock Shanghai Inquiry
Batchno.20260323 25mg In stock Shanghai Inquiry
Batchno.20250712 50mg In stock Shanghai Inquiry
Batchno.20251224 5mg In stock Shanghai Inquiry
Batchno.20251015 5mg / 25mg / 100mg / 250mg Confirm by inquiry Shanghai 5-7 business days Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260308 100mg Out of stock Inquiry
Batchno.20250213 10mg In stock Inquiry
Batchno.20260508 25mg In stock Inquiry
Batchno.20250831 50mg In stock Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250829 1ml In stock Inquiry
  • Product code: SSC-046858
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 1g
  • Available purity: ≥95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 1373422-53-7
Pack Size Recorded Purity Available Qty Ship From Inquiry
1g ≥95% 0 Out of Stock Shenzhen Inquiry

1373422-53-7 / 3-[[2-pyridin-2-yl-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)pyrimidin-4-yl]amino]propanoic acid

Standard CAS: 1373422-53-7 Multi CAS: No

Basic Information

CAS
1373422-53-7
Multi CAS
No
Molecular Formula
C22H23N5O2
Molecular Weight
389.400000
Exact Mass
389.185175
SMILES
C1CN(CCC2=CC=CC=C21)C3=NC(=NC(=C3)NCCC(=O)O)C4=CC=CC=N4
InChI
InChI=1S/C22H23N5O2/c28-21(29)8-12-24-19-15-20(26-22(25-19)18-7-3-4-11-23-18)27-13-9-16-5-1-2-6-17(16)10-14-27/h1-7,11,15H,8-10,12-14H2,(H,28,29)(H,24,25,26)
InChIKey
AVZCPICCWKMZDT-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
29
Aromatic heavy atom count
18
Fraction Csp3
0.27
Rotatable bonds
6
H-bond acceptors
6
H-bond donors
2
Molar refractivity
112.07
TPSA
91.24

LogP / Solubility

WLOGP
3.03
MLOGP
2.69
XLogP3
3.6
Consensus LogP
3.11
Log S (ESOL)
-4.23
Class (ESOL)
Slightly soluble
Log S (Ali)
-4.94
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-5.43
Class (SILICOS-IT)
Slightly soluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.94

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3

Safety & Transport

Pictogram(s)
Irritant
Signal
Warning
GHS Hazard Statements
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
Precautionary Statement Codes
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501

Get In Touch

Contact Us